{"title":"Overview of the Complexities in Diagnosing Treating and Preventing Tuberculosis along with the Most Effective Dosage Plans","authors":"Awan Sj","doi":"10.23880/ipcm-16000236","DOIUrl":null,"url":null,"abstract":"Mycobacterium tuberculosis is the name of the bacterium that causes tuberculosis (TB), which typically affects the lungs. Lifetime exposure to TB bacteria increases the risk of developing TB by 5–10%. A person’s likelihood of getting sick rises if they lead an unhealthy lifestyle or have a compromised immune system. A person may take several months before showing symptoms of active TB disease. As a result, getting medical help may take longer, and the virus may spread to more people. Rifampicin, isoniazid, pyrazinamide, and ethambutol are given as part of the traditional treatment for pulmonary TB during the first two months, and then rifampicin and isoniazid are given for the following four months. For the treatment of multidrugresistant TB, levofloxacin, moxifloxacin, and bedaquiline are suggested.","PeriodicalId":298121,"journal":{"name":"International Journal of Pharmacognosy & Chinese Medicine","volume":"34 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmacognosy & Chinese Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23880/ipcm-16000236","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Mycobacterium tuberculosis is the name of the bacterium that causes tuberculosis (TB), which typically affects the lungs. Lifetime exposure to TB bacteria increases the risk of developing TB by 5–10%. A person’s likelihood of getting sick rises if they lead an unhealthy lifestyle or have a compromised immune system. A person may take several months before showing symptoms of active TB disease. As a result, getting medical help may take longer, and the virus may spread to more people. Rifampicin, isoniazid, pyrazinamide, and ethambutol are given as part of the traditional treatment for pulmonary TB during the first two months, and then rifampicin and isoniazid are given for the following four months. For the treatment of multidrugresistant TB, levofloxacin, moxifloxacin, and bedaquiline are suggested.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
